Novo Nordisk CEO: '80% of Wegovy pill customers' have never taken a GLP-1 before
Jun 9, 2026•Channel
AI Analysis
Data from YouTube Data API v3•Updated Just now
Video Overview
Video Details
Published1 month ago
Duration9:13
Video IDCBQg4yTTbEs
Languageen
CategoryNews & Politics
PrivacyPublic
Made for KidsNo
Video TypeRegular Video
Performance Metrics
Views785
Likes12
Comments3
Engagement Rate1.91%
Likes per 100 views1.53
Comments per 1K views3.82
Description
At the American Diabetes Association’s 2026 Scientific Sessions, CNBC’s Angelica Peebles sat down with Novo Nordisk CEO Mike Doustdar to discuss the launch of the Wegovy pill and how it became the best prescription drug launch in history.